Inari Medical Inc. (NARI)
NASDAQ: NARI
· Real-Time Price · USD
79.97
0.00 (0.00%)
At close: Feb 18, 2025, 3:59 PM
Inari Medical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -78.58M | -57.05M | -23.62M | -1.64M | -2.77M | -16.08M | -28.36M | -29.27M | -22.36M | -15.01M | -758K | 9.84M | 15.72M | 25.02M | 17.15M |
Depreciation & Amortization | 16.9M | 13.69M | 11.09M | 9.45M | 9.18M | 8.75M | 8.43M | 7.12M | 6.89M | 6.15M | 5.19M | 4.31M | 3.1M | 2.46M | 1.9M |
Stock-Based Compensation | 48.66M | 45.55M | 42.87M | 40.34M | 38.13M | 35.64M | 32.45M | 28.67M | 25.58M | 30.73M | 28.17M | 25.45M | 22.5M | 10.96M | 6.87M |
Other Working Capital | 33.76M | 40.46M | 26.81M | 30.21M | 32.72M | 18.71M | 15.78M | 6.11M | 4.01M | 7.13M | -1.86M | 7.04M | -3.99M | 896K | 3.99M |
Other Non-Cash Items | 44.98M | 35.02M | 2.34M | -7.67M | -3.16M | -2.84M | -2.83M | 973K | 507K | 205K | 222K | 143K | 147K | 144K | 163.29K |
Deferred Income Tax | -584K | -2.85M | -7.18M | -7.18M | -6.6M | -4.33M | n/a | n/a | 69K | 69K | -92K | 47K | 200K | 779K | 3.91M |
Change in Working Capital | 9.98M | 20.24M | 708K | 2.64M | 162K | -15.21M | -16.58M | -21.47M | -20.91M | -24.88M | -25.11M | -14.3M | -32.81M | -19.58M | -18.62M |
Operating Cash Flow | 14.18M | 27.41M | 25.65M | 35.93M | 34.94M | 5.94M | -6.88M | -13.97M | -10.22M | -2.74M | 7.62M | 25.49M | 8.86M | 19.79M | 11.36M |
Capital Expenditures | -12.6M | -10.5M | -7.15M | -6.2M | -5.58M | -6.28M | -8.17M | -9.95M | -10.89M | -13.32M | -15.13M | -13.64M | -13.31M | -10.23M | -6.12M |
Cash Acquisitions | -236.7M | -250.13M | -249M | -245.92M | 25.97M | 23.69M | 117.58M | 114.5M | 133.03M | 148.74M | 50M | 50M | n/a | n/a | n/a |
Purchase of Investments | -102.76M | -161.05M | -305.86M | -406.74M | -555.13M | -546.09M | -502.48M | -497.87M | -366.74M | -286.13M | -230.9M | -134.38M | -155.41M | -134.73M | -71.22M |
Sales Maturities Of Investments | 291.49M | 393.75M | 538.61M | 595.34M | 529.16M | 522.4M | 384.9M | 312.6M | 213M | 114M | 144M | 97M | 68M | 50M | n/a |
Other Investing Acitivies | 182.38M | 198.1M | 189.53M | 187.11M | -25.97M | -23.69M | -117.58M | -185.26M | -203.8M | -222.19M | -73.45M | -23.93M | -23.91M | -21.22M | -71.22M |
Investing Cash Flow | -60.57M | -14.49M | -14.81M | -58.02M | -31.55M | -29.97M | -125.75M | -195.22M | -164.63M | -185.46M | -102.02M | -51.02M | -100.73M | -94.96M | -77.34M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -30.25M | -30.26M |
Common Stock Repurchased | 5.28M | -2.85M | -2.57M | -2.57M | -2.57M | -2.57M | -1.75M | -1.75M | -2.51M | -2.51M | -1.46M | -1.46M | -731K | -731K | -25K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -5.75M | -10.41M | -10.01M | -8.75M | -8.03M | -6.86M | -6.11M | -5.68M | -4.61M | -4.18M | -3.1M | -1.49M | -639K | -396K | 118K |
Financial Cash Flow | -1.76M | -681K | -280K | 1.17M | 1.89M | 2.31M | 3.06M | 177.14M | 178.21M | 177.32M | 178.4M | 4.07M | 4.92M | -28.61M | 136.31M |
Net Cash Flow | -47.97M | 12.36M | 10.64M | -21.01M | 5.65M | -21.89M | -129.99M | -32.53M | 2.37M | -11.6M | 83.65M | -21.86M | -87.22M | -103.9M | 70.14M |
Free Cash Flow | 1.58M | 16.91M | 18.5M | 29.73M | 29.36M | -344K | -15.05M | -23.92M | -21.11M | -16.07M | -7.5M | 11.84M | -4.46M | 9.56M | 5.24M |